Chartwell Molecular Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHARTWELL MOLECULAR, and what generic and branded alternatives to CHARTWELL MOLECULAR drugs are available?
CHARTWELL MOLECULAR has eighty-eight approved drugs.
There are two tentative approvals on CHARTWELL MOLECULAR drugs.
Drugs and US Patents for Chartwell Molecular
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Molecular | METHOCARBAMOL | methocarbamol | TABLET;ORAL | 084756-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chartwell Molecular | BOSENTAN | bosentan | TABLET;ORAL | 210342-001 | Jan 3, 2020 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chartwell Molecular | HYDROCORTISONE | hydrocortisone | CREAM;TOPICAL | 040503-001 | Mar 12, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Chartwell Molecular
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chartwell Molecular | MYKROX | metolazone | TABLET;ORAL | 019532-001 | Oct 30, 1987 | 4,517,179 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.